<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(2)</volume><submitter>Kakani P</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>Increasing integration across medical services may have important implications for health care quality and spending. One major but poorly understood dimension of integration is between physician organizations and pharmacies for self-administered drugs or in-house pharmacies.&lt;h4>Objective&lt;/h4>To describe trends in the use of in-house pharmacies, associated physician organization characteristics, and associated drug prices.&lt;h4>Design, setting, and participants&lt;/h4>A cross-sectional study was conducted from calendar years 2011 to 2019. Participants included 20% of beneficiaries enrolled in fee-for-service Medicare Parts A, B, and D. Data analysis was performed from September 15, 2020, to December 20, 2023.&lt;h4>Exposures&lt;/h4>Prescriptions filled by in-house pharmacies.&lt;h4>Mai</pubmed_abstract><journal>JAMA network open</journal><pagination>e2356592</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10877451</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Trends in Integration Between Physician Organizations and Pharmacies for Self-Administered Drugs.</pubmed_title><pmcid>PMC10877451</pmcid><pubmed_authors>Kakani P</pubmed_authors><pubmed_authors>Rosenthal MB</pubmed_authors><pubmed_authors>Cutler DM</pubmed_authors><pubmed_authors>Keating NL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Trends in Integration Between Physician Organizations and Pharmacies for Self-Administered Drugs.</name><description>&lt;h4>Importance&lt;/h4>Increasing integration across medical services may have important implications for health care quality and spending. One major but poorly understood dimension of integration is between physician organizations and pharmacies for self-administered drugs or in-house pharmacies.&lt;h4>Objective&lt;/h4>To describe trends in the use of in-house pharmacies, associated physician organization characteristics, and associated drug prices.&lt;h4>Design, setting, and participants&lt;/h4>A cross-sectional study was conducted from calendar years 2011 to 2019. Participants included 20% of beneficiaries enrolled in fee-for-service Medicare Parts A, B, and D. Data analysis was performed from September 15, 2020, to December 20, 2023.&lt;h4>Exposures&lt;/h4>Prescriptions filled by in-house pharmacies.&lt;h4>Mai</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2025-04-05T00:29:41.734Z</modification><creation>2025-04-05T00:29:41.734Z</creation></dates><accession>S-EPMC10877451</accession><cross_references><pubmed>38373001</pubmed><doi>10.1001/jamanetworkopen.2023.56592</doi></cross_references></HashMap>